Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus
Clinical trial NCT00571519 · TERMINATED
Trial details
- NCT number
- NCT00571519
- Sponsor
- Daiichi Sankyo
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-14
- Primary completion
- 2008-05-23
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.